Alkermes Plc ALKS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EDT
22.33UNCH (UNCH)
Volume
223,382
Close
22.33quote price arrow down-0.13 (-0.58%)
Volume
1,699,086
52 week range
21.24 - 33.00
Loading...
  • Open22.51
  • Day High22.74
  • Day Low22.28
  • Prev Close22.46
  • 52 Week High33.00
  • 52 Week High Date10/07/21
  • 52 Week Low21.24
  • 52 Week Low Date12/01/21

Key Stats

  • Market Cap3.668B
  • Shares Out164.25M
  • 10 Day Average Volume1.30M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-4

KEY STATS

  • Open22.51
  • Day High22.74
  • Day Low22.28
  • Prev Close22.46
  • 52 Week High33.00
  • 52 Week High Date10/07/21
  • 52 Week Low21.24
  • 52 Week Low Date12/01/21
  • Market Cap3.668B
  • Shares Out164.25M
  • 10 Day Average Volume1.30M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-4

RATIOS/PROFITABILITY

  • EPS (TTM)-0.58
  • P/E (TTM)-38.56
  • Fwd P/E (NTM)-305.89
  • EBITDA (TTM)803,000.00
  • ROE (TTM)-8.64%
  • Revenue (TTM)1.173B
  • Gross Margin (TTM)81.53%
  • Net Margin (TTM)-8.02%
  • Debt To Equity (MRQ)27.21%

EVENTS

  • Earnings Date10/26/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alkermes Plc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Alkermes Public Limited Company is a fully integrated biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. It has a portfolio of commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. The Company's products...
Richard Pops
Chairman of the Board, Chief Executive Officer
Blair Jackson
Chief Operating Officer, Executive Vice President
Iain Brown
Chief Financial Officer, Senior Vice President
Craig Hopkinson M.D.
Executive Vice President, Research and Development and Chief Medical Officer
Address
Connaught HSE, 1 Burlington Road
Dublin
00000
Ireland